SAFE-TAVI Study: Safety and Efficacy of the Pressure Sensor and Pacing Guidewire

Currently, we observe an increase in the number of transcatheter aortic valve replacement (TAVR) procedures due to its expansion toward a younger population with lower risk. For this reason, it is crucial to maintain continuous technological innovation to minimize post-procedural complications.

Estudio SAFE-TAVI: Seguridad y eficacia de la guía para marcapasear y censar presiones

The FDA has approved the SavyWire, a preformed 0.035-caliber guidewire that offers three essential functions: 1) it facilitates prosthesis transport and positioning; 2) it allows for continuous hemodynamic monitoring through a distal optical fiber sensor; 3) it enables pacing through the left ventricle.

The main objective of this prospective multicenter study, named SAFE-TAVI (SavvyWire Efficacy and Safety in Transcatheter Aortic Valve Implantation Procedures), was to assess the safety and efficacy of the SavyWire in TAVR, using both balloon-expandable and self-expandable valves.

The primary endpoint (PEP) was defined as rapid and effective pacing with a significant decrease in pressure (reduction of systolic pressure below 60 mmHg). The secondary safety endpoint (SSE) included the absence of major guidewire-related complications.

Researchers analyzed a total of 119 patients with a mean age of 82.2 ± 5.9 years, 49.6% of whom were women. The average STS Score was 3.85. All patients were treated via transfemoral access. Balloon-expandable valves were used in 37.8% of cases. Predilation was performed in 74.8% of subjects and postdilation in 11.8% of patients.

Read also: Heterotopic Tricuspid Intervention: TricValve One-Year Outcomes.

Regarding the PEP, a drop in systolic pressure below 60 mmHg was achieved in 98.3% of patients, and the mean arterial systolic pressure during rapid pacing was 46.6 ± 11.3 mm Hg. The SSE was reached in 99.2% of patients, with no mortality, stroke, guidewire kinking, or ventricular perforation events.

Conclusion

The results of this study demonstrate the safety and efficacy of the SavyWire during TAVR. This device can contribute to minimizing intervention during the procedure and improving clinical outcomes after transcatheter aortic valve implantation.

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Safety and Efficacy of Transcatheter Aortic Valve Replacement With a Pressure Sensor and Pacing Guidewire SAFE-TAVI Trial.

Reference: Ander Regueiro, MD, PHD et al J Am Coll Cardiol Intv 2023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

TAVR in Young Low-Risk Patients

Transcatheter aortic valve replacement (TAVR) has established itself as an effective strategy for the treatment of severe aortic stenosis across different risk groups. While previous...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...